SYNTHESIS OF CARBAMOYL PYRIDONE INHIBITORS OF HIV INTEGRASE AND INTERMEDIATE COMPOUNDS Russian patent published in 2014 - IPC C07D491/147 C07D471/22 A61K31/4355 A61K31/436 A61K31/437 A61P31/18 

Abstract RU 2527451 C2

FIELD: chemistry.

SUBSTANCE: invention relates to improved method of obtaining pyridine compounds (AA),(BB) and (CC) of respective formulas:

,

,

.

said compounds possess inhibiting action with respect to HIV-integrase. method consists in carrying out the following stages: P-1) bromination of compound of formula (I-I) with obtaining bromine-compound of formula (II-II)

,

where value R represents -CHO, -CH(OH)2, -CH(OH)(OR4), -CH(OH)-CH2OH or -CH(OR5)(OR6); P1 represents benzyl; P3 represents H or protective group of carboxyl; R4 represents lower alkyl; R5 and R6 independently represent lower alkyl or R5 and R6 can represent alkyl and be connected with formation of 5-, 6- or 7-member ring, P-2) formation of side chain of 2,4-di-fluorophenyl-CH2-NH-C(O)- with application of reagents 2,4-di-fluorophenyl-CH2-NH2 and carbon monoxide, stage of formation of Q ring by means of respective amine, selected from 3-amino-butan-1-ol, 2-amino-propan-1-ol and 2-pyrrolidinyl methylamine, and stage of debenzylation with obtaining compound of formula (AA), (BB) or (CC), where said stage P-2 is carried out after formation of Q ring.

EFFECT: method makes it possible to simplify obtaining target compounds due to carrying out regioselective bromination at the first stage.

6 cl, 3 ex, 7 dwg

Similar patents RU2527451C2

Title Year Author Number
SYNTHESIS OF CARBAMOIL-PYRIDONE INHIBITORS OF HIV INTEGRASE AND INTERMEDIATE COMPOUNDS 2013
  • Joshida Khiroshi
  • Taoda Joshiyuki
  • Dzhons Brajan Alvin
  • Kavasuzhi Takashi
  • Nagamatsu Daiki
RU2638923C2
HUMAN IMMUNODEFICIENCY VIRUS REPLICATION INHIBITORS 2019
  • Dzhillis Erik P.
  • Parsella Kajl E.
  • Patel Manoj
  • Pise Kevin M.
RU2812128C2
ISOINDOLINE COMPOUND, PRODUCTION METHOD, PHARMACEUTICAL COMPOSITION AND THEIR USE 2019
  • Chen, Xiaohua
  • Li, Jia
  • Cheng, Yu
  • Zhou, Yubo
  • Nie, Huijun
  • Wang, Yujie
  • Tian, Hongtao
  • Kan, Weijuan
  • Mi, Tian
  • Hu, Xiaobei
  • Zhou, Binshan
  • Yan, Kenian
  • Xu, Gaoya
  • Zhong, Yuhua
  • Feng, Lei
RU2813232C2
DERIVATIVES OF 3-SUBSTITUTED 4-ARYLQUINOLIN-2-ONE AS MODULATORS OF POTASSIUM CHANNEL 1999
  • Khevavasam Pijazena
  • Starrett Dzhon E. Ml.
RU2240998C2
INHIBITORS OF METALLOPROTEINASES, THEIR USING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 2002
  • Ehriksson Anders
  • Lepiste Matti
  • Lundkvist Mikaehl'
  • Munk Af Rozenskel'D Magnus
  • Zlatojdskij Pavol
RU2288228C2
PRODRUG FORMING COMPOUNDS 2014
  • Nikish Klaus
  • Santamma Bindu
  • Akhmed Gulzar
  • Mis Frederik
  • Elger Valter
  • Virma Ralf
  • Nair Kharesh
RU2667942C2
C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS 2017
  • Chen Jie
  • Chen Yan
  • Dicker Ira B.
  • Hartz Richard A
  • Meanwell Nicholas A
  • Nowicka-Sans Beata
  • Regueiro-Ren Alicia
  • Sit Sing-Yuen
  • Sin Ny
  • Swidorski Jacob
  • Venables Brian Lee
RU2716502C2
ACTIVE COMPOUNDS WITH RESPECT TO BROMO-DOMAINS 2015
  • Gerner Seitzberg Jimmi
  • Titilola Akinleminu Kronborg Tine
  • Poljak Visnja
  • Friberg Gitte
  • Teuber Lene
RU2743074C2
PYRAZINE COMPOUNDS AND THEIR USE 2019
  • Qi Changhe
  • Tsui Honchung
  • Zeng Qingbei
  • Yang Zhenfan
  • Zhang Xiaolin
RU2809631C2
CYCLIC DI-NUCLEOTIDE COMPOUNDS FOR TREATMENT OF CANCER 2018
  • Kim, Dae-Shik
  • Fang, Frenk
  • Endo, Atsushi
  • Choi, Kheong-Vuk
  • Khao, Min-Khon
  • Bao, Tsinfen
  • Khuan, Kuan-Chun
RU2790175C2

RU 2 527 451 C2

Authors

Yoshida, Hiroshi

Taoda, Yoshiyuki

Jons, Brian Alvin

Kawasuji, Takashi

Nagamatsu, Daiki

Dates

2014-08-27Published

2009-12-08Filed